]>
IRCT2013112515533N1 IRCT 2014-08-20 Mashhad University of Medical Sciences ,Vice chancellor for research Effect of camel milk on chronic hepatitis C investigating the effects of Camel Milk Products on the laboratory markers in the patients with chronic hepatitis, genotype 2 & 3 2014-07-23 anticipated 40 Complete https://irct.ir/trial/14779 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2 Chronic hepatitis C. Intervention 1: Intervention group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally daily and camel milk 250 cc daily in the morning and night for three months. Intervention 2: Control group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally for three months.
public Mohammadreza Noras
Faculty of Traditional Medicine
Mashhd Iran (Islamic Republic of) +98 51 3855 2189 norasmr901@mums.ac.ir Faculty of Traditional Medicine scientific Seyyd Musa Al-Reza Hosseini
Ahmadabad Street, Department of Medicine Internal, Ghaem Hospital, Mashhad
Mashhd Iran (Islamic Republic of) +98 51 3801 2742 HoseiniMR@mums.ac.ir Department of Medicine Internal Clinic, Ghaem Hospital Iran (Islamic Republic of) Iran (Islamic Republic of) inclusion criteria: age 18 to 70 yearsØ› the detection of serum HCV RNA by PCR. exclusion criteria:Decompensated cirrhosis; autoimmune diseases; cancer; infected with HIVorHBV;neutropenia;thrombocytopenia; creatinine higher;organ transplant;severe heart disease; chronic lung disease; uncontrolled psychiatric illness; epilepsy; diabetic retinopathy; active alcohol or addiction; pregnancy;anemia;non-compliance with the prescribed dosage milk; discourage patients from continuing to participate in the plan; other genotypesto participate in the plan; other genotypes 18 years 70 years Both B18.2 Chronic viral hepatitis C Treatment - Drugs Treatment - Drugs Intervention group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally daily and camel milk 250 cc daily in the morning and night for three months. Control group: Pegah interferon (Pgasys) at a dose of 180 mcg subcutaneously once weekly, and ribavirin dose of 800 to 1200 mg based on body weight orally for three months. Quantification of HCV RNA. Timepoint: One Month. Method of measurement: PCR. Level of ALT,AST. Timepoint: One Month. Method of measurement: unit /ml. Razi vaccine and Serum research Institue of Mashhd Mashhad University of Medical Sciences ,Vice chancellor for research Razi vaccine and Serum research Institue of Mashhd Approved 2014-07-16 Ethics committee, Mashhad University of Medical Sciences Ghoreishi Building, Danehgah Street,Vice chancellor for research, University of Medical Sciences, Mashhad Mashhad Iran (Islamic Republic of)